Congratulations to Dr Matthew! 🎉
He successfully defended his PhD on hollow-core photonic crystal fibres for studying flavin-based photocatalysts. We’re so proud of his work and excited to see his impact as a postdoc at @EarlyCancerCam@Cambridge_Uni!
The clay's the thing! 🪣
Research conducted at CEB has developed a brand new material from clay and vitamin B2 that could clean-up pollutants using nothing but sunlight.
More: https://t.co/AdZYhDSfOO
🧪⚙️🌱🔋
#ChemicalEngineering#Biotechnology#CambridgeUniversity@FrukLab
🌟Out now & on the cover of @CatalysisSciTec !
Meet Flaponite – our recyclable, flavin-based photocatalyst using LAPONITE clay as a green support. Enhanced activity, easy recovery, and inspired by nature!
Congrats Matthew & the whole team!👏
🔗https://t.co/TMlapi3YeE
In this article, we discuss three key challenges holding back the clinical translation of targeted nanomedicine:
👤 Pharmacokinetics of nanoparticle antibody conjugates; turns out they are not as straightforward as it seems
If you're interested in targeted nanomedicine (and open to some opinions), check out our latest piece:
"Reimagining drug nanocarriers: clinical realities and smarter strategies for targeted drug delivery"
https://t.co/aR3qA1DKEB
We're delighted to announce the 2025 Danckwerts-Pergamon prize has been awarded to Muhammad Hartono for his innovative work on non-invasive lung cancer screening.
Read more on our website: https://t.co/5s3QBaVX73
🧪⚙️🌱🔋
#ChemicalEngineering#Biotechnology#Cambridge